Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M103578200 on May 22, 2001

J. Biol. Chem., Vol. 276, Issue 29, 27335-27344, July 20, 2001
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/29/27335    most recent
M103578200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grewal, J. S.
Right arrow Articles by Raymond, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grewal, J. S.
Right arrow Articles by Raymond, J. R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

G Protein-coupled Receptors Desensitize and Down-regulate Epidermal Growth Factor Receptors in Renal Mesangial Cells*

Jasjit S. GrewalDagger , Louis M. Luttrell§, and John R. RaymondDagger ||

From the Dagger  Nephrology Division, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina 29425, the  Research and Medical Specialty Services, Ralph H. Johnson Veterans Affairs Medical Center, Charleston, South Carolina 29401, and the § Endocrinology Division, Department of Medicine, Duke University Medical Center and Geriatric Research, Education, and Clinical Center, Durham Veterans Affairs Medical Center, Durham, North Carolina 27710

Different types of plasma membrane receptors engage in various forms of cross-talk. We used cultures of rat renal mesangial cells to study the regulation of EGF receptors (EGFRs) by various endogenous G protein-coupled receptors (GPCRs). GPCRs (5-hydroxytryptamine2A, lysophosphatidic acid, angiotensin AT1, bradykinin B2) were shown to transactivate EGFRs through a protein kinase C-dependent pathway. This transactivation resulted in the initiation of multiple cellular signals (phosphorylation of the EGFRs and ERK and activation of cAMP-responsive element-binding protein (CREB), NF-kappa B, and E2F), as well as subsequent rapid down-regulation of cell-surface EGFRs and internalization and desensitization of the EGFRs without change in the total cellular complement of EGFRs. Internalization of the EGFRs and the down-regulation of cell-surface receptors in mesangial cells were blocked by pharmacological inhibitors of clathrin-mediated endocytosis and in HEK293 cells by transfection of cDNA constructs that encode dominant negative beta -arrestin-1 or dynamin. Whereas all of the effects of GPCRs on EGFRs were dependent to a great extent on protein kinase C, those initiated by EGF were not. These studies demonstrate that GPCRs can induce multiple signals through protein kinase C-dependent transactivation of EGFRs. Moreover, GPCRs induce profound desensitization of EGFRs by a process associated with the loss of cell-surface EGFRs through clathrin-mediated endocytosis.


* This work was supported by the Department of Veterans Affairs (merit award to J. R. R.), the National Institutes of Health (Grants DK52448 and DK54720 to J. R. R. and DK55524 to L. M. L.), a fellowship from the American Heart Association (to J. S. G.), and a laboratory endowment jointly supported by the Division of Nephrology, Medical University of South Carolina and Dialysis Clinics, Inc. (to J. R. R.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

|| To whom correspondence should be addressed: Rm. 829 Clinical Sciences Building, Medical University of South Carolina, 171 Ashley Ave., Charleston, SC 29425. Tel.: 843-792-4122; Fax: 843-792-8399; E-mail: raymondj@musc.edu.


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
K. M. Kassel, N. A. Schulte, S. M. Parker, A. D. Lanik, and M. L. Toews
Lysophosphatidic Acid Decreases Epidermal Growth Factor Receptor Binding in Airway Epithelial Cells
J. Pharmacol. Exp. Ther., October 1, 2007; 323(1): 109 - 118.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
K. Y. Chung and J. W. Walker
Interaction and Inhibitory Cross-Talk between Endothelin and ErbB Receptors in the Adult Heart
Mol. Pharmacol., June 1, 2007; 71(6): 1494 - 1502.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Gooz, P. Gooz, L. M. Luttrell, and J. R. Raymond
5-HT2A Receptor Induces ERK Phosphorylation and Proliferation through ADAM-17 Tumor Necrosis Factor-{alpha}-converting Enzyme (TACE) Activation and Heparin-bound Epidermal Growth Factor-like Growth Factor (HB-EGF) Shedding in Mesangial Cells
J. Biol. Chem., July 28, 2006; 281(30): 21004 - 21012.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. A. Olivares-Reyes, B. H. Shah, J. Hernandez-Aranda, A. Garcia-Caballero, M. P. Farshori, J. A. Garcia-Sainz, and K. J. Catt
Agonist-Induced Interactions between Angiotensin AT1 and Epidermal Growth Factor Receptors
Mol. Pharmacol., August 1, 2005; 68(2): 356 - 364.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
H. M. El-Shewy, F. L. Kelly, L. Barki-Harrington, and L. M. Luttrell
Ectodomain Shedding-Dependent Transactivation of Epidermal Growth Factor Receptors in Response to Insulin-Like Growth Factor Type I
Mol. Endocrinol., November 1, 2004; 18(11): 2727 - 2739.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
B. H. Shah, A. Yesilkaya, J. A. Olivares-Reyes, H.-D. Chen, L. Hunyady, and K. J. Catt
Differential Pathways of Angiotensin II-Induced Extracellularly Regulated Kinase 1/2 Phosphorylation in Specific Cell Types: Role of Heparin-Binding Epidermal Growth Factor
Mol. Endocrinol., August 1, 2004; 18(8): 2035 - 2048.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
D. Mitchell, K. Rodgers, J. Hanly, B. McMahon, H. R. Brady, F. Martin, and C. Godson
Lipoxins Inhibit Akt/PKB Activation and Cell Cycle Progression in Human Mesangial Cells
Am. J. Pathol., March 1, 2004; 164(3): 937 - 946.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. V. Mukhin, M. N. Garnovskaya, M. E. Ullian, and J. R. Raymond
ERK Is Regulated by Sodium-Proton Exchanger in Rat Aortic Vascular Smooth Muscle Cells
J. Biol. Chem., January 16, 2004; 279(3): 1845 - 1852.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. H. Shah, M. P. Farshori, and K. J. Catt
Neuropeptide-induced Transactivation of a Neuronal Epidermal Growth Factor Receptor Is Mediated by Metalloprotease-dependent Formation of Heparin-binding Epidermal Growth Factor
J. Biol. Chem., January 2, 2004; 279(1): 414 - 420.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. M. Belcheva, Y. Tan, V. M. Heaton, A. L. Clark, and C. J. Coscia
{micro} Opioid Transactivation and Down-Regulation of the Epidermal Growth Factor Receptor in Astrocytes: Implications for Mitogen-Activated Protein Kinase Signaling
Mol. Pharmacol., December 1, 2003; 64(6): 1391 - 1401.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
I. Ahmed, D. Gesty-Palmer, M. K. Drezner, and L. M. Luttrell
Transactivation of the Epidermal Growth Factor Receptor Mediates Parathyroid Hormone and Prostaglandin F2{alpha}-Stimulated Mitogen-Activated Protein Kinase Activation in Cultured Transgenic Murine Osteoblasts
Mol. Endocrinol., August 1, 2003; 17(8): 1607 - 1621.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. H. Shah, J.-W. Soh, and K. J. Catt
Dependence of Gonadotropin-releasing Hormone-induced Neuronal MAPK Signaling on Epidermal Growth Factor Receptor Transactivation
J. Biol. Chem., January 24, 2003; 278(5): 2866 - 2875.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
B. H. Shah, J. Alberto Olivares-Reyes, A. Yesilkaya, and K. J. Catt
Independence of Angiotensin II-Induced MAP Kinase Activation from Angiotensin Type 1 Receptor Internalization in Clone 9 Hepatocytes
Mol. Endocrinol., March 1, 2002; 16(3): 610 - 620.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement